MD1390Z - Метод идентификации маркера анти-Toxocara IgG в сыворотке крови - Google Patents
Метод идентификации маркера анти-Toxocara IgG в сыворотке крови Download PDFInfo
- Publication number
- MD1390Z MD1390Z MDS20190001A MDS20190001A MD1390Z MD 1390 Z MD1390 Z MD 1390Z MD S20190001 A MDS20190001 A MD S20190001A MD S20190001 A MDS20190001 A MD S20190001A MD 1390 Z MD1390 Z MD 1390Z
- Authority
- MD
- Moldova
- Prior art keywords
- ntu
- toxocara
- samples
- result
- ratio
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 27
- 210000002966 serum Anatomy 0.000 title claims abstract description 21
- 239000003550 marker Substances 0.000 title claims abstract description 17
- 238000012360 testing method Methods 0.000 claims abstract description 21
- 230000003287 optical effect Effects 0.000 claims abstract description 12
- 239000005995 Aluminium silicate Substances 0.000 claims abstract description 10
- 235000012211 aluminium silicate Nutrition 0.000 claims abstract description 10
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 claims abstract description 10
- 241000244030 Toxocara canis Species 0.000 claims abstract description 7
- 239000000725 suspension Substances 0.000 claims abstract description 7
- 239000013642 negative control Substances 0.000 claims abstract description 5
- 206010044269 Toxocariasis Diseases 0.000 abstract description 15
- 239000003814 drug Substances 0.000 abstract description 4
- 238000002965 ELISA Methods 0.000 description 11
- 208000015181 infectious disease Diseases 0.000 description 7
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 230000035945 sensitivity Effects 0.000 description 5
- 229920003355 Novatec® Polymers 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 241000244031 Toxocara Species 0.000 description 4
- 238000003759 clinical diagnosis Methods 0.000 description 4
- 238000011835 investigation Methods 0.000 description 4
- RLAWWYSOJDYHDC-BZSNNMDCSA-N lisinopril Chemical compound C([C@H](N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(O)=O)C(O)=O)CC1=CC=CC=C1 RLAWWYSOJDYHDC-BZSNNMDCSA-N 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 208000030852 Parasitic disease Diseases 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- YRNWIFYIFSBPAU-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=C(N(C)C)C=C1 YRNWIFYIFSBPAU-UHFFFAOYSA-N 0.000 description 1
- 241000244184 Ascarididae Species 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 238000009007 Diagnostic Kit Methods 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000022811 deglycosylation Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000003771 laboratory diagnosis Methods 0.000 description 1
- 230000001418 larval effect Effects 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 238000009589 serological test Methods 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Изобретение относится к медицине, а именно к методу идентификации маркера анти-Toxocara IgG в сыворотке крови и может быть использовано для диагностики токсокароза человека.Сущность изобретения состоит в исследовании сыворотки крови в иммуноферментном тесте с использованием микропланшета с адсорбированным Ag toxocara canis и определением значения оптической плотности образцов фотометрическим методом при длине волны 450 нм, затем определяют соотношение средней величины оптической плотности сыворотки пациента х 10 и средней величины оптической плотности проб с отрицательным контролем, и если соотношение составляет до 9 NTU, считается что результат отрицательный, если он больше 11 NTU, результат положительный, а пробы с результатом 9...11 NTU обрабатывают 25%-ой суспензией каолина, затем повторяют иммуноферментный тест с последующим определением указанного соотношения для определения отрицательного результата, если соотношение составляет до 9 NTU, и положительным, если больше 11 NTU.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDS20190001A MD1390Z (ru) | 2019-01-11 | 2019-01-11 | Метод идентификации маркера анти-Toxocara IgG в сыворотке крови |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDS20190001A MD1390Z (ru) | 2019-01-11 | 2019-01-11 | Метод идентификации маркера анти-Toxocara IgG в сыворотке крови |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD1390Y MD1390Y (ru) | 2019-11-30 |
| MD1390Z true MD1390Z (ru) | 2020-06-30 |
Family
ID=68732604
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDS20190001A MD1390Z (ru) | 2019-01-11 | 2019-01-11 | Метод идентификации маркера анти-Toxocara IgG в сыворотке крови |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD1390Z (ru) |
-
2019
- 2019-01-11 MD MDS20190001A patent/MD1390Z/ru not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| MD1390Y (ru) | 2019-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Buffet et al. | Diagnosing Treponema pallidum in secondary syphilis by PCR and immunohistochemistry | |
| Al-Sherbiny et al. | Application of immunodiagnostic assays: detection of antibodies and circulating antigens in human schistosomiasis and correlation with clinical findings. | |
| Voordouw et al. | Performance of Zika assays in the context of Toxoplasma gondii, parvovirus B19, rubella virus, and cytomegalovirus (TORCH) diagnostic assays | |
| Al-Harthi et al. | Diagnosis and differentiation of Entamoeba infection in Makkah Al Mukarramah using microscopy and stool antigen detection kits | |
| DK174032B1 (da) | Sæt samt fremgangsmåde til immunometrisk dosering, der kan anvendes på hele celler | |
| JP4531314B2 (ja) | 合成抗原を用いて梅毒を発見するための方法 | |
| JP2009537013A (ja) | フラビウイルス特異的抗体の検出のための抗原捕捉抗デングＩｇＡＥＬＩＳＡ（ＡＣＡ−ＥＬＩＳＡ） | |
| JP2009537013A6 (ja) | フラビウイルス特異的抗体の検出のための抗原捕捉抗デングＩｇＡ ＥＬＩＳＡ（ＡＣＡ−ＥＬＩＳＡ） | |
| Yilmaz et al. | Are tonsils a reservoir for Helicobacter pylori infection in children? | |
| Tayeb et al. | The impact of Toxoplasma gondii infection on the vitamin D3 levels among women in childbearing age in Kirkuk Province-Iraq | |
| Wagenaar et al. | Rapid serological assays for leptospirosis are of limited value in southern Vietnam | |
| Smith et al. | Diagnosis of human Giardiasis | |
| KR20130142874A (ko) | B형 만성 간염의 검출 방법 및 검출 키트 | |
| Hashoosh et al. | Comparison of two assays in the diagnosis of toxoplasmosis: immunological and molecular | |
| Abbas et al. | Prevalence of Giardia lamblia in diarrheic children in Almadinah Almunawarh, KSA | |
| MD1390Z (ru) | Метод идентификации маркера анти-Toxocara IgG в сыворотке крови | |
| Salman et al. | Evaluation of the employment of four laboratory diagnostic methods of detecting Gairdia lamblia among Children in Kirkuk city | |
| US20100279319A1 (en) | Detection of plasmodium falciparum histidine-rich protein II in saliva malaria patients | |
| US6379906B1 (en) | Compositions and methods for detecting adult Taenia solium | |
| Sato | Laboratorial diagnosis of syphilis | |
| Amin et al. | Correlation between Interleukin-6, Toxoplasmosis, and Cytomegalovirus in Novel COVID (nCoV-19) patients in Kirkuk–Iraq | |
| JP2010539479A (ja) | 月経液、子宮内膜／月経細胞、羊水、臍帯血又は他の試料の感染症検査 | |
| CN113624977A (zh) | SARS-CoV-2感染诊断方法 | |
| Abdulali | Seroprevalence of antibodies against to RCH infectious pathogens (Toxoplasma gondii, Rubella and cytomegalovirus) among pregnant women in El-Beida City | |
| Maw et al. | Laboratory diagnostics for strongyloidiasis: conventional and novel techniques |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG9Y | Short term patent issued | ||
| KA4Y | Short-term patent lapsed due to non-payment of fees (with right of restoration) |